Moore's Compounding Pharmacy recalls
Moore's Compounding Pharmacy has 1 recall on record with the FDA and USDA, the earliest in 2017 and the latest reported on 1 Mar 2017. The most frequent reason is potency & assay.
Total recalls1since 2017
Last 12 months0reported
Class I00% of total
Ongoing0latest 1 Mar 2017
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why moore's compounding pharmacy is recalled
Product types
By year
All moore's compounding pharmacy recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Levothyroxine Sodium 135 mcg/Liothyronine recalled | Moore's Compounding Pharmacy | Potency & Assay | TX |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.